Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2022	Aug. 01, 2021
Cash flows from operating activities:
Net income	$ 123,978	$ 50,185
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	61,210	69,305
Share-based compensation	4,623	4,034
Changes in assets and liabilities:
Accounts receivable	(45,199)	(13,854)
Inventories	1,570	5,073
Other current assets	661	(12,280)
Accounts payable, accrued liabilities, and other	49,078	10,633
Net cash provided by operating activities	195,921	113,096
Cash flows from investing activities:
Purchases of property, plant and equipment	(46,337)	(92,301)
Government incentives	1,394	5,775
Other	(179)	(170)
Net cash used in investing activities	(45,122)	(86,696)
Cash flows from financing activities:
Repayments of debt	(51,917)	(13,311)
Purchases of treasury stock	(2,522)	(35,750)
Contributions from noncontrolling interest	24,995	0
Proceeds from share-based arrangements	5,505	2,251
Proceeds from long-term debt	0	20,858
Net settlements of restricted stock awards	(1,463)	(403)
Net cash used in financing activities	(25,402)	(26,355)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	(21,308)	4,602
Net increase in cash, cash equivalents, and restricted cash	104,089	4,647
Cash, cash equivalents, and restricted cash at beginning of period	279,680	281,602
Cash, cash equivalents, and restricted cash at end of period	383,769	286,249
Less: Ending restricted cash	2,936	3,000
Cash and cash equivalents at end of period	380,833	283,249
Supplemental disclosures of non-cash information:
Accruals for property, plant and equipment purchased during the period	$ 5,558	$ 7,367